News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
381,738 Results
Type
Article (25927)
Company Profile (59)
Press Release (355752)
Multimedia
Podcasts (25)
Webinars (7)
Section
Business (104274)
Career Advice (449)
Deals (16875)
Drug Delivery (51)
Drug Development (47605)
Employer Resources (47)
FDA (12262)
Job Trends (8443)
News (185947)
Policy (19424)
Tag
Academia (1750)
Accelerated approval (3)
Adcomms (8)
Allergies (73)
Alliances (26748)
ALS (57)
Alzheimer's disease (811)
Antibody-drug conjugate (ADC) (51)
Approvals (12326)
Artificial intelligence (170)
Autoimmune disease (11)
Automation (4)
Bankruptcy (142)
Best Places to Work (6895)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (39)
Bladder cancer (59)
Brain cancer (17)
Breast cancer (192)
Cancer (1430)
Cardiovascular disease (119)
Career advice (407)
Career pathing (13)
CAR-T (70)
Cell therapy (199)
Cervical cancer (13)
Clinical research (40521)
Collaboration (442)
Compensation (126)
Complete response letters (9)
COVID-19 (1493)
CRISPR (12)
C-suite (139)
Cystic fibrosis (42)
Data (1525)
Decentralized trials (2)
Denatured (17)
Depression (30)
Diabetes (174)
Diagnostics (3521)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (54)
Drug shortages (21)
Duchenne muscular dystrophy (55)
Earnings (36917)
Editorial (20)
Employer branding (6)
Employer resources (44)
Events (51800)
Executive appointments (448)
FDA (13249)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (402)
Gene editing (36)
Generative AI (10)
Gene therapy (126)
GLP-1 (401)
Government (3035)
Grass and pollen (3)
Guidances (42)
Healthcare (12186)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (40)
Indications (19)
Infectious disease (1563)
Inflammatory bowel disease (79)
Inflation Reduction Act (4)
Influenza (26)
Intellectual property (50)
Interviews (40)
IPO (7041)
IRA (19)
Job creations (1840)
Job search strategy (378)
Kidney cancer (7)
Labor market (10)
Layoffs (169)
Leadership (4)
Legal (3632)
Liver cancer (57)
Lung cancer (232)
Lymphoma (100)
Machine learning (3)
Management (17)
Manufacturing (104)
MASH (48)
Medical device (12906)
Medtech (12909)
Mergers & acquisitions (10123)
Metabolic disorders (432)
Multiple sclerosis (54)
NASH (11)
Neurodegenerative disease (49)
Neuropsychiatric disorders (9)
Neuroscience (1144)
NextGen: Class of 2025 (3930)
Non-profit (2822)
Now hiring (16)
Obesity (218)
Opinion (70)
Ovarian cancer (52)
Pain (64)
Pancreatic cancer (53)
Parkinson's disease (88)
Partnered (11)
Patents (112)
Patient recruitment (82)
Peanut (37)
People (34724)
Pharmaceutical (17)
Pharmacy benefit managers (11)
Phase I (11609)
Phase II (17539)
Phase III (14416)
Pipeline (686)
Policy (59)
Postmarket research (1668)
Preclinical (3616)
Press Release (18)
Prostate cancer (76)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (183)
Real estate (2847)
Recruiting (16)
Regulatory (14212)
Reports (16)
Research institute (1607)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (51)
Series A (66)
Series B (48)
Service/supplier (3)
Sickle cell disease (21)
Special edition (3)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2121)
Stomach cancer (8)
Supply chain (38)
Tariffs (11)
The Weekly (8)
Vaccines (353)
Venture capitalists (13)
Weight loss (141)
Women's health (17)
Worklife (4)
Date
Today (63)
Last 7 days (461)
Last 30 days (1401)
Last 365 days (18465)
2025 (5891)
2024 (19856)
2023 (22739)
2022 (30681)
2021 (32985)
2020 (32197)
2019 (28428)
2018 (21812)
2017 (18906)
2016 (18111)
2015 (21194)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (354)
Alabama (17)
Alaska (2)
Arizona (118)
Arkansas (10)
Asia (24554)
Australia (3887)
California (3049)
Canada (1218)
China (372)
Colorado (165)
Connecticut (172)
Delaware (115)
Europe (47928)
Florida (542)
Georgia (126)
Idaho (33)
Illinois (358)
India (14)
Indiana (223)
Iowa (3)
Japan (119)
Kansas (73)
Kentucky (12)
Louisiana (7)
Maine (27)
Maryland (634)
Massachusetts (2141)
Michigan (107)
Minnesota (270)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (33)
New Hampshire (60)
New Jersey (1124)
New Mexico (9)
New York (953)
North Carolina (553)
North Dakota (4)
Northern California (1334)
Ohio (131)
Oklahoma (3)
Oregon (23)
Pennsylvania (824)
Puerto Rico (7)
Rhode Island (24)
South America (520)
South Carolina (21)
Southern California (1169)
Tennessee (77)
Texas (537)
United States (12771)
Utah (111)
Virginia (80)
Washington D.C. (39)
Washington State (228)
West Virginia (3)
Wisconsin (42)
381,738 Results for "inari medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment
February 19, 2025
·
3 min read
Press Releases
Inari Medical to Present at the J.P. Morgan Healthcare Conference
January 3, 2025
·
1 min read
Press Releases
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases
March 7, 2025
·
5 min read
Press Releases
Inari Medical Announces Joint Venture in Greater China
December 3, 2024
·
4 min read
Business
Inari Medical Reports First Quarter 2024 Financial Results
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its first quarter ended March 31, 2024.
April 30, 2024
·
10 min read
Press Releases
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
January 17, 2025
·
6 min read
Biotech Beach
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
Inari Medical, Inc. announced the publication of its 2023 Ethos and Sustainability Report.
April 11, 2024
·
1 min read
Business
Inari Medical to Announce First Quarter 2024 Financial Results
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its first quarter 2024 financial results on Tuesday, April 30, 2024.
April 17, 2024
·
1 min read
Biotech Beach
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference
Inari Medical, Inc. announced its management team will present at the upcoming Bank of America Securities Healthcare Conference on Wednesday, May 15, 2024, at 11:20 AM Pacific Time.
May 6, 2024
·
1 min read
Press Releases
Inari Medical to Participate in the Jefferies London Healthcare Conference 2024
November 7, 2024
·
1 min read
1 of 38,174
Next
